RxDoctor Payments Data

Gretchen Lorenz, MD

Family Medicine · Piqua, OHNPI 1710100425

Payments from drug & device makers

$1,386in general payments, 2019–2025

Across 97 payments — averaging $14.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$319
  • AstraZeneca$239
  • Lilly USA, LLC$165
  • Pfizer$145
  • GSK$139
  • Novo Nordisk$106
  • plus $274 from 10 others

What the payments were for

  • Food & beverage$1,386100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,386 in reported general payments places this provider in the 65th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$79,385
Medicare patients
225
Services billed
1,189

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin96$122,832
Soliqua 100-33Insulin Glargine/Lixisenatide97$91,414
OzempicSemaglutide29$49,366
Trelegy ElliptaFluticasone/Umeclidin/Vilanter44$39,332
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog35$33,328
TrulicityDulaglutide22$28,203
EliquisApixaban22$23,545
XareltoRivaroxaban34$20,463
LinzessLinaclotide18$18,474
NamzaricMemantine Hcl/Donepezil Hcl16$11,392
FarxigaDapagliflozin Propanediol14$9,438
Combivent RespimatIpratropium/Albuterol Sulfate16$7,602
Duloxetine Hcl168$5,233
Lantus SolostarInsulin Glargine,hum.Rec.Anlog32$4,279
Celecoxib54$3,566

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Combivent Respimat$85$130,434112 claims
Sanofi-aventis U.S. LLCSoliqua 100-33$34$91,41497 claims
Novo NordiskOzempic$106$49,36629 claims
GSKTrelegy Ellipta$139$39,33244 claims
AbbVieLinzess, Namzaric$319$29,86634 claims
Lilly USA, LLCTrulicity$165$28,20322 claims
PfizerEliquis$145$23,54522 claims
AstraZenecaFarxiga$239$9,43814 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Piqua

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →